Roy, Pushpita, Dipaloke Banik, Forhad Chowdhury, and Md Abu Bakar Siddique. “Magnitude of Survival Benefit Associated With Tyrosine Kinase Inhibitors in Advanced Thyroid Carcinoma: A Systematic Review and Meta-Analysis Incorporating Updated Long-Term Evidence From SELECT (Lenvatinib) and COSMIC-311 (Cabozantinib) Trials”. World Journal of Oncology 17, no. 5 (January 1, 2026): 599–613. Accessed September 5, 2026. https://wjon.elmerpub.com/wjon/article/view/2842.